Maximon Pharma

Delhi, India Founded: 2018 • Age: 8 yrs
Supplies and exports pharmaceutical products, medicines, and health supplements globally.

About Maximon Pharma

Maximon Pharma is a Healthcare company based in Delhi (India) founded in 2018. It supplies and exports pharmaceutical products, medicines, and health supplements globally. It operates on a B2B and B2C model. The company has 8 employees. Its Indian entity Maximon Pharma Private Limited reported revenue of β‚Ή1.55 Cr. Maximon Pharma offers products and services including AntiFlux D, Calcigem D, Durasol D3, Neurorize OD Plus, and Diclopentin. Its focus areas include Pharmaceuticals, Medicines, General Wellbeing and Health Supplements. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Maximon Pharma Private Limited, based in New Delhi, India, operates as a supplier and exporter of various medicines and health supplements. The company focuses on providing high-quality products at affordable prices to domestic and international markets, including areas like musculoskeletal and female healthcare. They emphasize reliability and aim to improve patient quality of life through cost-effective solutions. Backed by an experienced team, they handle distribution and exports efficiently.

  • Headquarters Delhi, India
  • Employees 8
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website maximonwellness.com
  • Legal Name Maximon Pharma Private Limited
  • Date of Incorporation 12 Jun, 2018
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹1.55 Cr

    FY 2025 · +30% YoY

  • Net Profit
    ₹18.4 Lakh

    FY 2025 · 12% margin

  • EBITDA
    ₹12.1 Lakh

    FY 2025 · 8% margin

  • Employee Count
    8

Products & Services of Maximon Pharma

Maximon Pharma offers a comprehensive portfolio of products and services, including AntiFlux D, Calcigem D, Durasol D3, Neurorize OD Plus, and Diclopentin.

AntiFlux D
Medicine

Medicine aimed at treating acid-related conditions effectively.

Calcigem D
Health Supplement

Supplement for bone health and calcium support in daily use.

Durasol D3
Health Supplement

Vitamin D supplement to aid immune and bone functions regularly.

Neurorize OD Plus
Medicine

Medication for nerve health and overall wellbeing support.

Diclopentin
Medicine

Pain relief medicine for musculoskeletal issues and discomfort.

Maxi QL
Health Supplement

Supplement promoting general health and quality of life improvements.

Board of directors of Maximon Pharma Private Limited (Maximon Pharma)

Maximon Pharma Private Limited is the primary company behind Maximon Pharma. The board of Maximon Pharma Private Limited currently have 6 directors; the longest-serving is Harshavardhan Karunakar Hegde, appointed in 2018. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Harshavardhan Karunakar Hegde
DIN 03050173
Director12 Jun 20188 yrs 5 moMaximon Pharma Private Limited
Akshay Kumar Saxena
DIN 08155730
Director12 Jun 20188 yrs 5 moMaximon Pharma Private Limited
Rakesh Mattoo
DIN 06587788
Director12 Jun 20188 yrs 5 moMaximon Pharma Private Limited
Sarita Kapur
DIN 08848507
Director01 Aug 20215 yrs 3 moMaximon Pharma Private Limited
Anjali Harshavardhan Hegde
DIN 01683723
Director01 Aug 20215 yrs 3 moMaximon Pharma Private Limited
Arundhati Hegde
DIN 09010739
Director01 Aug 20215 yrs 3 moMaximon Pharma Private Limited

Financials of Maximon Pharma

Figures of Maximon Pharma Private Limited, the primary company behind Maximon Pharma, for FY 2025. Revenue was ₹1.55 Cr (+30% year on year). Net profit was ₹18.4 Lakh (12% margin). EBITDA was ₹12.1 Lakh (8% margin). Revenue has grown at a compounded annual rate of -11% over three years and +18% over five years.

  • ₹1.55 CrRevenue · FY 2025 · +30% YoY
  • ₹18.4 LakhNet profit · 12% margin
  • ₹12.1 LakhEBITDA · 8% margin
  • ₹1 LakhPaid-up capital
  • 8Employees (provident fund records)
  • -11%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Maximon Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Maximon Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Maximon Pharma

Maximon Pharma has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Maximon Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Maximon Pharma

Maximon increases investment volume
Startupticker β€’ 3 years ago
Premium access

Complete news archive for Maximon Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maximon Pharma

Maximon Pharma was founded in 2018.

Maximon Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Maximon Pharma has 8 employees.

The primary company behind Maximon Pharma, Maximon Pharma Private Limited, reported revenue of β‚Ή1.55 Cr for FY 2025, up 30% year on year.

Maximon Pharma Private Limited, based in New Delhi, India, operates as a supplier and exporter of various medicines and health supplements. The company focuses on providing high-quality products at affordable prices to domestic and international markets, including areas like musculoskeletal and female healthcare. They emphasize reliability and aim to improve patient quality of life through cost-effective solutions. Backed by an experienced team, they handle distribution and exports efficiently.

Maximon Pharma's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Maximon Pharma offers AntiFlux D, Calcigem D, Durasol D3, Neurorize OD Plus, and 2 more products and services.

Maximon Pharma operates through Maximon Pharma Private Limited.

The legal entities of Maximon Pharma currently have 6 directors, including Sarita Kapur, Harshavardhan Karunakar Hegde, Akshay Kumar Saxena and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available